Key result
End-stage renal failure is linked to a ~67% reduction in human calcitonin clearance.
Why the study?
The metabolic clearance rate and distribution characteristics of radioiodinated synthetic human calcitonin in normal humans and end-stage renal failure patients were not well characterized.
What is the metabolic clearance rate of radioiodinated human calcitonin in normal subjects compared to patients with end-stage renal failure?
Observational (n=26)
Yes
What is the metabolic clearance rate of radioiodinated human calcitonin in normal subjects compared to patients with end-stage renal failure?
The kidneys play an important role in the utilization and/or degradation of human calcitonin, as evidenced by its considerably lower metabolic clearance rate in patients with end-stage renal failure.
Answers are grounded in this paper and cite their sources.
Calcitonin dosing may require adjustment in ESRD; leaves open need for outcome studies in renal impairment.
The characteristics of the disappearance of radioiodinated synthetic human calcitonin from plasma have been studied in man. After single injection the disappearance curve was multiexponential. The number of exponentials of the theoretical curve fitting the best with the experimental data varied individually. Metabolic clearance rate was determined both from single injection and constant infusion studies, and fast initial distribution volume from the former. Metabolic clearance rate values in normal man calculated from constant infusion studies were 82.3 +/-3.4 ml/min per m(2). Values derived from single injection studies were similar, 77.0 +/-4.7 ml/min per m(2). These results were compared to those obtained in end stage, renal failure patients. Metabolic clearance rate was considerably lower and volume of fast initial distribution slightly larger in that group. This fact emphasizes the important role of kidneys in the utilization and/or the degradation of human calcitonin.
No takes yet. Share an insight, caveat, or question.
Ardaillou et al. (1970) conducted an observational in End-stage renal failure (n=26). End-stage renal failure vs. Normal renal function was evaluated on Metabolic clearance rate (MCR) of radioiodinated human calcitonin from single injection studies (p=<0.01). End-stage renal failure reduced the metabolic clearance rate of human calcitonin to 25.4 ml/min per m2 compared to 77.0 ml/min per m2 in normal subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: